EUVIMEDOdkrijte EUVIMED
Open access

Organophosphate Ester Flame Retardants and Plasticizers in Relation to Fetal Growth in the LIFECODES Fetal Growth Study

Paige A Bommarito, Danielle R Stevens, Barrett M Welch, Maria Ospina, Antonia M Calafat, John D Meeker, David E Cantonwine, Thomas F McElrath, Kelly K Ferguson

Environmental Health Perspectives · 2024-07 · 132 (7)

DOI: 10.1289/ehp14647 ↗

At a glance

Journal article in Environmental Health Perspectives, 2024-07. Written by Paige A Bommarito and 8 co-authors. Institution: Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, US…. Major MEDLINE topics: Flame Retardants, Fetal Development, Plasticizers, Maternal Exposure. Cited 21 times so far (Crossref); 69 references. The full text is freely available in PubMed Central. Funded by: NIEHS NIH HHS.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

BACKGROUND: Organophosphate esters (OPEs), used ubiquitously as flame retardants and plasticizers in consumer products, are suspected of having developmental toxicity. OBJECTIVES: Our study aimed to estimate associations between prenatal exposure to OPEs and fetal growth, including both ultrasound (head circumference, abdominal circumference, femur length, and estimated fetal weight) and delivery [birth weight z-score, small-for-gestational age (SGA), and large-for-gestational age (LGA)] measures of growth. METHODS: In the LIFECODES Fetal Growth Study (2008-2018), an enriched case-cohort of 900 babies born at the small and large ends of the growth spectrum, we quantified OPE biomarkers in three urine samples per pregnant participant and abstracted ultrasound and delivery measures of fetal growth from medical records. We estimated associations between pregnancy-averaged log-transformed OPE biomarkers and repeated ultrasound measures of fetal growth using linear mixed-effects models, and delivery measures of fetal growth using linear (birth weight) and logistic (SGA and LGA) regression models. RESULTS: Most OPE biomarkers were positively associated with at least one ultrasound measure of fetal growth, but associations with delivery measures were largely null. For example, an interquartile range (IQR; 1.31 ng/mL) increase in bis(2-chloroethyl) phosphate concentration was associated with larger z-scores in head circumference [mean difference (difference): 0.09; 95% confidence interval (CI): 0.01, 0.17], abdominal circumference (difference: 0.10; 95% CI: 0.02, 0.18), femur length (difference: 0.11; 95% CI: 0.03, 0.19), and estimated fetal weight (difference: 0.13; 95% CI: 0.04, 0.22) but not birth weight (difference: 0.04; 95% CI: -0.08, 0.17). At delivery, an IQR (1.00 ng/mL) increase in diphenyl phosphate (DPHP) concentration was associated with an SGA birth (odds ratio: 1.46; 95% CI: 1.10, 1.94). CONCLUSIONS: In a large prospective cohort, gestational OPE exposures were associated with larger fetal size during pregnancy, but associations at delivery were null. DPHP concentrations were associated with heightened risk of an SGA birth. These findings suggest that OPE exposure may affect fetal development. https://doi.org/10.1289/EHP14647.

Subjects

MeSH terms (MEDLINE)

Flame RetardantsFetal DevelopmentPlasticizersMaternal ExposureHumansFemalePregnancyOrganophosphatesAdultBirth WeightInfant, NewbornEstersBiomarkersCohort StudiesMale

Substances

Flame RetardantsPlasticizersOrganophosphatesEstersBiomarkers

Authors and institutions

  • Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
  • School of Public Health, University of Nevada, Reno, Nevada, USA.
  • Division of Laboratory Sciences, National Center for Environmental Health, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Department of Environmental Health Sciences, University of Michigan School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Funding

  • NIEHS NIH HHS

Cite

APA

Bommarito, P. A., Stevens, D. R., Welch, B. M., Ospina, M., Calafat, A. M., Meeker, J. D., Cantonwine, D. E., McElrath, T. F., & Ferguson, K. K. (2024). Organophosphate Ester Flame Retardants and Plasticizers in Relation to Fetal Growth in the LIFECODES Fetal Growth Study. Environmental Health Perspectives. https://doi.org/10.1289/ehp14647

Vancouver

Bommarito PA, Stevens DR, Welch BM, Ospina M, Calafat AM, Meeker JD, et al. Organophosphate Ester Flame Retardants and Plasticizers in Relation to Fetal Growth in the LIFECODES Fetal Growth Study. Environmental Health Perspectives. 2024. doi:10.1289/ehp14647

BibTeX
@article{Bommarito2024,
  author = {Bommarito, Paige A and Stevens, Danielle R and Welch, Barrett M and Ospina, Maria and Calafat, Antonia M and Meeker, John D and Cantonwine, David E and McElrath, Thomas F and Ferguson, Kelly K},
  title = {Organophosphate Ester Flame Retardants and Plasticizers in Relation to Fetal Growth in the LIFECODES Fetal Growth Study},
  journal = {Environmental Health Perspectives},
  year = {2024},
  doi = {10.1289/ehp14647}
}
Start for free →